|4Jan 28, 6:07 PM ET

Duato Joaquin 4

4 · JOHNSON & JOHNSON · Filed Jan 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Johnson & Johnson (JNJ) CEO Joaquin Duato Sells 100,000 Shares

What Happened

  • Joaquin Duato, CEO and Chairman of Johnson & Johnson, sold a total of 100,000 JNJ shares in open-market transactions on January 26, 2026. He sold 51,218 shares at a weighted-average price of $220.99 for $11,318,461 and 48,782 shares at a weighted-average price of $221.48 for $10,804,432, for combined proceeds of $22,122,893. These transactions are coded as sales (S) — dispositions rather than purchases.

Key Details

  • Transaction date: 2026-01-26; Form filed: 2026-01-28 (appears timely).
  • Prices: Weighted averages reported as $220.99 and $221.48. Footnotes state the trades were executed in multiple fills with price ranges of $220.39–$221.376 (F1) and $221.38–$221.64 (F2).
  • Shares sold: 51,218 and 48,782 (total 100,000). Total proceeds: $22,122,893.
  • Shares owned after transaction: Not disclosed in the provided Form 4.
  • Notable footnotes: F1/F2 explain multiple-trade executions and weighted-average reporting; F3 notes reported holdings include shares from dividend reinvestment in the Johnson & Johnson Savings Plan as of 12/31/2025. The filer offers to provide full trade-level details on request.
  • Transaction type: Open-market sale (not an option exercise, gift, or award).

Context

  • Open-market sales by executives are common and often reflect routine portfolio or tax planning; they do not, by themselves, indicate insider views on company fundamentals. This filing does not show any option exercises or awards associated with these sales. Joaquin Duato is reported as CEO and Chairman (not a 10% owner in this filing).

Insider Transaction Report

Form 4
Period: 2026-01-26
Duato Joaquin
DirectorCEO and Chairman of the Board
Transactions
  • Sale

    Common Stock

    [F1]
    2026-01-26$220.99/sh51,218$11,318,46179,634 total(indirect: By Spouse)
  • Sale

    Common Stock

    [F2]
    2026-01-26$221.48/sh48,782$10,804,43230,852 total(indirect: By Spouse)
Holdings
  • Common Stock

    275,967
  • Common Stock

    [F3]
    (indirect: By 401(k))
    988
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025).
Signature
/s/ Joleen Morgan, as attorney-in-fact for Joaquin Duato|2026-01-28

Documents

1 file
  • 4
    wk-form4_1769641662.xmlPrimary

    FORM 4